Calderin Sollet, Zuleika
Schäfer, Antonia
Ferrari-Lacraz, Sylvie
Masouridi-Levrat, Stavroula http://orcid.org/0000-0001-7502-5454
Mamez, Anne-Claire
Pradier, Amandine
Simonetta, Federico
Chalandon, Yves http://orcid.org/0000-0001-9341-8104
Villard, Jean http://orcid.org/0000-0003-2667-7506
Buhler, Stéphane http://orcid.org/0000-0001-6675-5287
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_173237/1)
Société Académique de Genève
IRGHET (International Research Group on unrelated Hematopoietic stem cell Transplantation), the Dr. Henri Dubois-Ferrière Dinu Lippatti foundation and the Philanthropy Settlement
Article History
Received: 23 December 2022
Revised: 25 January 2023
Accepted: 1 February 2023
First Online: 16 February 2023
Competing interests
: YC: consulting fees from MSD, Novartis, Incyte, BMS, Pfizer, Abbvie, Roche, Jazz, Gilead, Amgen, Astra-Zeneca, Servier; Travel support from MSD, Roche, Gilead, Amgen, Incyte, Abbvie, Janssen, Astra-Zeneca, Jazz. The other authors declare no competing interests.